Subsidies & Funding

We empower medical innovation

Project Management

We manage research & innovation projects

Business Strategy

We support successful commercialisation


ttopstart and Merck Ventures present the Biotechnology Showcase on Cancer and Cancer Immunology

February 21 2017

Public-Private-Partnerships (PPPs) are becoming increasingly important. Not only because translational and applied research is sometimes difficult to finance with non-dilutive funds, but also because it is vital that there is an early engagement of investors and industry in early stages of development. This is essential to guide a product through the rocky waters of preclinical research, clinical trials, validation and marketing approval.

For this purpose, ttopstart BV and Merck Ventures have decided to organise a biotechnology showcase for leading researchers and high potentials in the field of cancer and cancer immunology, scheduled May 3 2017.  
This is the only European showcase focusing on very early scientific innovation – both investors and candidates are selected for this specific purpose.

About the Biotechnology Showcase Europe

The Biotechnology Showcase is a dedicated intimate event to bring together investors and academic researchers with an ambition to commercialise their ideas.

This research focused partnering conference provides researchers, with innovative breakthrough developments, with an opportunity to pitch to, and meet with, venture capital and pharmaceutical executives during the course of one day. Academic and industry professionals come together in the beautiful environment of Amsterdam and the Royal Tropical Institute.

We are specifically interested in cutting-edge science supported by (novel) in-house data on crucial elements of the scientific hypothesis, e.g. proof of principle. Ideally, in vitro or in vivo proof of concept would be present but this is not mandatory.

Biotechnology Showcase Contest

In addition to the invited speakers that will pitch their business ideas, ttopstart and Merck Ventures have organised a contest to select two Pitch Proposals that will win a spot to pitch their concepts to the audience, a developed business case by ttopstart professionals and a travel-voucher to visit the Showcase*.

Are you this entrepreneurial researcher with a breakthrough idea in the field of cancer or cancer immunity?

Do you want to pitch among the leading researchers in your field to an audience of major Venture Capital firms and Pharmaceutical companies**?

Please visit, join the competition and submit your pitch proposal using the special 2-page template!

Information for pharmaceutical executives and investors

Are you a pharmaceutical executive or a public private investor, and interested to join the audience? Please e-mail us and inform whether we still have a seat available!


ttopstart has ample experience in supporting public-private projects and other funding applications. Please email us and find how our services fit your needs.

* a round trip for one person is reimbursed from a location in Europe to Amsterdam worth up to €200,-

** Confirmed Venture Capital Firms & Pharmaceutical companies: LSP, Biogeneration Ventures, Merck Ventures, Aglaia, Forbion, MSD, Pfizer, Kite Pharma

Share this